Zanzalintinib, CAS [[2367004-54-2]]

Product Overview

• Article Name: Zanzalintinib, CAS [[2367004-54-2]]
• Biozol Catalog Number: MCE-HY-138696
• Supplier Catalog Number: HY-138696
• Alternative Catalog Number: MCE-HY-138696-5MG,MCE-HY-138696-10MG,MCE-HY-138696-10MMX1ML,MCE-HY-138696-50MG,MCE-HY-138696-25MG,MCE-HY-138696-100MG
• Manufacturer: MedchemExpress
• Category: Biochemikalien
• Alternative Names: XL092

Product Description

Zanzalintinib (XL092) is an orally active, ATP-competitive inhibitor of multiple receptor tyrosine kinases (RTKs) including MET, VEGFR2, AXL and MER, with IC50s in cell-based assays of 15 nM, 1.6 nM, 3.4 nM, 7.2 nM respectively. Zanzalintinib exhibits anti-tumor activity. Zanzalintinib has the potential for kinase-dependent diseases and conditions research[1][2].

Product Properties

• Molecular Weight: 528.53
• Purity: 99.91
• CAS Number: [2367004-54-2]
• Formula: C29H25FN4O5
• Target: c-Met/HGFR,TAM Receptor,VEGFR

Application Notes

• Application Notes: Reference compound